Henry joined Auron in June 2022 as a computational biologist. Prior to Auron, Henry was a Principal Scientist of molecular discovery at BioMedicine Design Pfizer in Cambridge MA, where he supported antibody drug discovery and optimization across multiple portfolio programs. He played an active role in developing experimental and bioinformatic methods to profile antibody repertoires using next-generation sequencing. Henry also served as antibody engineering lead for an immunology preclinical program, where he executed antibody lead identification and characterized therapeutic mechanisms of action. Prior to Pfizer, Henry was a graduate student at Scripps Research, where he developed improved phage antibody selection methods and applied them to identify tumor cell surface antigens. Henry holds a PhD in Biochemistry from Scripps and a bachelor’s degree from the University of Michigan.
Henry resides in Watertown with his wife, daughter, and two cats. He enjoys playing chess, doing yard work, camping, hiking, snowboarding, and playing sports.